Role of interferon alpha (IFN-α) and interferon gamma (IFN-γ) in the control of the infection of monocyte-like cells with human cytomegalovirus (HCMV)

被引:12
作者
Delannoy, AS [1 ]
Hober, D [1 ]
Bouzidi, A [1 ]
Wattre, P [1 ]
机构
[1] CHU Lille, Inst Gernez Rieux, Virol Lab, F-59037 Lille, France
关键词
human cytomegalovirus; MRC-5; cells; THP-1; IFNs;
D O I
10.1111/j.1348-0421.1999.tb03365.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The role of cytokines in the control of HCMV infection has been studied in THP-1 cells, a macrophage-like cell model and in MRCS cells. HCMV replication was studied by immune detection of viral immediate-early antigens (IEA) and virus yield was evaluated in MRC-5 cells by immunoperoxidase staining, Pretreatment of MRC-5 and phorbol 12-myristate 13-acetate (PMA)-treated THP-1 cells with IFN-alpha or IFN-gamma for 24 hr prior to the infection reduced the number of infected cells and virus yield. A synergistic anti-CMV activity in synthesis of early proteins was obtained with these cytokines in combination with TNF-alpha in differentiated THP-1 cells only. Treatment of HCMV-infected differentiated THP-1 cells or MRC-5 cells with IFN-alpha or IFN-gamma alone had no inhibitory effect on virus replication, however the virus yield was reduced with ganciclovir, A synergistic anti-CMV activity in virus yield was obtained only when infected differentiated THP-1 cells were treated with ganciclovir in combination with IFN-gamma. The current study shows that IFN-alpha and IFN-gamma can play a role in the reduction of HCMV replication in macrophage-like cells and in the efficiency of therapies with ganciclovir in this cell type and that the anti-CMV effect of cytokines may be different in fibroblasts and in macrophage-like cells.
引用
收藏
页码:1087 / 1096
页数:10
相关论文
共 37 条
[1]
BAB M, 1984, ANTIMICROB AGENTS CH, V25, P515
[2]
METALLOPROTEASES AND SERINE PROTEASES ARE INVOLVED IN THE CLEAVAGE OF THE 2 TUMOR-NECROSIS-FACTOR (TNF) RECEPTORS TO SOLUBLE FORMS IN THE MYELOID CELL-LINES U-937 AND THP-1 [J].
BJORNBERG, F ;
LANTZ, M ;
GULLBERG, U .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 42 (04) :418-424
[3]
BUCHMEIER NA, 1989, IMMUNOLOGY, V66, P278
[4]
INTERFERON AS A DEFENSE-MECHANISM IN MOUSE CYTOMEGALOVIRUS-INFECTION [J].
CHONG, KT ;
GRESSER, I ;
MIMS, CA .
JOURNAL OF GENERAL VIROLOGY, 1983, 64 (FEB) :461-464
[5]
ASSOCIATION OF A M(R)-90,000 PHOSPHOPROTEIN WITH PROTEIN-KINASE PKR IN CELLS EXHIBITING ENHANCED PHOSPHORYLATION OF TRANSLATION INITIATION-FACTOR EIF-2-ALPHA AND PREMATURE SHUTOFF OF PROTEIN-SYNTHESIS AFTER INFECTION WITH GAMMA(1)34.5(-) MUTANTS OF HERPES-SIMPLEX-VIRUS-1 [J].
CHOU, J ;
CHEN, JJ ;
GROSS, M ;
ROIZMAN, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10516-10520
[6]
Anti-human cytomegalovirus activity of cytokines produced by CD4(+) T-cell clones specifically activated by IE1 peptides in vitro [J].
Davignon, JL ;
Castanie, P ;
Yorke, JA ;
Gautier, N ;
Clement, D ;
Davrinche, C .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2162-2169
[7]
Delannoy AS, 1997, PATHOL BIOL, V45, P394
[9]
CYTOMEGALOVIRUS-INFECTION OF HUMAN-BLOOD CELLS [J].
EINHORN, L ;
OST, A .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (02) :207-214